2 studies found for:    17087947 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Lipid Efficacy/Tolerability Study
Conditions: Primary Hypercholesterolaemia;   Mixed Hyperlipidaemia
Interventions: Drug: niacin (+) laropiprant;   Drug: ER-niacin
2 Completed A Study to Evaluate the Effect of MK0966 (Rofecoxib) on the Recurrence of Colorectal Adenomas (0966-122)(COMPLETED)
Condition: Colorectal Adenona
Interventions: Drug: MK0966; Rofecoxib / Duration of Treatment: 156 weeks;   Drug: Placebo/ Duration of Treatment: 156 weeks

Indicates status has not been verified in more than two years